Close
Nordic 9Nordic 9

Deerfield Management (investor - Private Equity)

United States deerfield.com
See something wrong or missing? Let us know
Offices:New York
Average round investment:71.47M USD
Average number per year:1.3
Distribution: 2024 (2)2023 (1)2022 (1)
Portfolio companies: United Kingdom Relation TherapeuticsItaly Medical Micro InstrumentsUnited Kingdom Ascend Gene & Cell Therapies
Mostly invests in: United Kingdom United Kingdom (2) Manufacturing (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Deerfield Management

Name Criteria
China GT Healthcare Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Health services, Robotics, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Julius Bär Group
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Cowen Healthcare Investments
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Artis Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Arch Venture Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Kairos
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States What If Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Patient Square Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Schroders
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Switzerland Mirabaud Asset Management
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Top